Showing 14,581 - 14,600 results of 44,452 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 5 ((nn decrease) OR (mean decrease)) ))', query time: 0.76s Refine Results
  1. 14581
  2. 14582

    S1 Dataset - by Riham Saud Alhazmy (19697677)

    Published 2024
    “…</p><p>Results</p><p>The mean HbA1c level decreased from 8.61 ± 1.70 to 7.92 ± 1.60 after implementing the WhatsApp group instructions; the values showed a significant difference (t-value = 5.107 and <i>P</i>-value < 0.001). …”
  3. 14583

    Particepant recruitment flowchart. by Riham Saud Alhazmy (19697677)

    Published 2024
    “…</p><p>Results</p><p>The mean HbA1c level decreased from 8.61 ± 1.70 to 7.92 ± 1.60 after implementing the WhatsApp group instructions; the values showed a significant difference (t-value = 5.107 and <i>P</i>-value < 0.001). …”
  4. 14584

    Flow of participants through the study. by Sedighe Esmaeilzadeh (21100668)

    Published 2025
    “…Participants were randomly assigned to receive either 5 mg melatonin or placebo for 2 months. The primary outcome was change in overall sleep quality as measured by the Pittsburgh Sleep Quality Index (PSQI). …”
  5. 14585

    Demographic Characteristics of Participants. by Sedighe Esmaeilzadeh (21100668)

    Published 2025
    “…Participants were randomly assigned to receive either 5 mg melatonin or placebo for 2 months. The primary outcome was change in overall sleep quality as measured by the Pittsburgh Sleep Quality Index (PSQI). …”
  6. 14586
  7. 14587
  8. 14588

    Transforming Small-Molecule Nanoaggregation into Functional Drug Delivery Platforms by JunHyuk Kim (21235657)

    Published 2025
    “…The IC<sub>50</sub> value of <b>Nano-CC1-Acl</b> further decreases to 0.20 ± 0.16 μM in the presence of cysteine, a biothiol. …”
  9. 14589

    Transforming Small-Molecule Nanoaggregation into Functional Drug Delivery Platforms by JunHyuk Kim (21235657)

    Published 2025
    “…The IC<sub>50</sub> value of <b>Nano-CC1-Acl</b> further decreases to 0.20 ± 0.16 μM in the presence of cysteine, a biothiol. …”
  10. 14590
  11. 14591

    An overview of study characteristics. by Akhmedkhan Dubayev (17879559)

    Published 2024
    “…</p><p>Results</p><p>Twenty-five studies were included (5 randomized controlled trials, 20 non-randomized controlled trials). …”
  12. 14592

    Summary of NOS bias assessments. by Akhmedkhan Dubayev (17879559)

    Published 2024
    “…</p><p>Results</p><p>Twenty-five studies were included (5 randomized controlled trials, 20 non-randomized controlled trials). …”
  13. 14593

    QST characteristics. by Akhmedkhan Dubayev (17879559)

    Published 2024
    “…</p><p>Results</p><p>Twenty-five studies were included (5 randomized controlled trials, 20 non-randomized controlled trials). …”
  14. 14594
  15. 14595

    Characteristics of cell line models. by Katarzyna Monika Lamperska (4217602)

    Published 2017
    “…The let-7d expression levels were similar, but the MEAN of GFP fluorescence marker was nearly half lower in the 7d7d line than in 7d. …”
  16. 14596

    Effects of Common Polymorphisms rs11614913 in <em>miR-196a2</em> and rs2910164 in <em>miR-146a</em> on Cancer Susceptibility: A Meta-Analysis by Wei Xu (28953)

    Published 2011
    “…Rs11614913 in <em>miR-196a2</em> and rs2910164 in <em>miR-146a</em> are shown to associate with increased/decreased cancer risk. …”
  17. 14597
  18. 14598

    MiR-29a targets PTEN. by Guangyao Kong (185282)

    Published 2011
    “…Empty pcDNA3.0 plasmid (200 ng) was used as a negative control. (C) Luciferase reporter gene assay showed that the decreased luciferase activities of PTEN 3′UTR reporter (PTEN 3′UTR-1 or PTEN 3′UTR-2) in HepG2 cells mediated by miR-29a overexpression (200 ng) was rescued by a miR-29a inhibitor in a dose dependent manner (30, 50, and 100 nM). …”
  19. 14599

    Modulation of Aβ-induced deleterious signaling. by Tao Yang (184280)

    Published 2008
    “…<p>For each study, LM11A-24 and -31 were present at 100 nM and NGF at 50 or 100 ng/ml. …”
  20. 14600

    Effects of sialidase treatment on substantia nigra dopamine neurons. by Jay S. Schneider (671374)

    Published 2015
    “…<p>Sub-acute MPTP treatment (aCSF-MPTP) resulted in significant decreases in the number of tyrosine hydroxylase immunopositive (A.) and Nissl-stained (B.) cells in the substantia nigra pars compacta. …”